-
Loading metrics
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
-
Westley J. Friesen ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: wfriesen@ptcbio.com
Affiliation PTC Therapeutics, South Plainfield, NJ, United States of America
⨯ - Briana Johnson,
- Jairo Sierra,
- Jin Zhuo,
- Priya Vazirani,
- Xiaojiao Xue,
- Yuki Tomizawa,
- Ramil Baiazitov,
- Christie Morrill,
- Hongyu Ren,
- Suresh Babu,
- Young-Choon Moon,
- Art Branstrom,
- Anna Mollin,
- Jean Hedrick,
- Josephine Sheedy,
- Gary Elfring,
- Marla Weetall,
- Joseph M. Colacino,
- Ellen M. Welch,
- [ ... ],
- Stuart W. Peltz
- [ view all ]
- [ view less ]
http://orcid.org/0000-0002-6191-2973
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
- Westley J. Friesen,
- Briana Johnson,
- Jairo Sierra,
- Jin Zhuo,
- Priya Vazirani,
- Xiaojiao Xue,
- Yuki Tomizawa,
- Ramil Baiazitov,
- Christie Morrill,
- Hongyu Ren
x
- Published: October 25, 2018
- https://doi.org/10.1371/journal.pone.0206158